Ungayinyanga njani iHepatitis C

Umxholo

• Unyango lokunyanga iHepatitis C
• Ndazi njani ukuba ndinyangekile kwi-hepatitis C
• Iziphumo ebezingalindelekanga zamayeza

I-Hepatitis C iyanyangeka ngamayeza amiselwe ngugqirha, kodwa kuxhomekeke kuhlobo lonyango olwenziweyo unyango lungahluka phakathi kwe-50 kunye ne-100%.

Inkqubo yonyango eyenziweyo nge-Interferon ayisebenzi kangako kwaye ayingabo bonke abantu abaphilisiweyo kwaye yiyo loo nto kusenokwenzeka ukuba ihlale inentsholongwane esibindini nasemva kokuphela konyango, kwimeko apho umntu aya kuthiwa une-hepatitis engapheliyo. C. Nangona kunjalo, isikimu sonyango esitsha savunywa ngu-Anvisa ngo-2016 kwaye sinamathuba amakhulu okunyanga, ahluka phakathi kwama-80 kunye ne-100% kwaye ngale ndlela intsholongwane inokupheliswa ngokupheleleyo esibindini.

Unyango lokunyanga iHepatitis C

Ngokwesiqhelo, unyango lwe-hepatitis C lwenziwa ngokusetyenziswa kwamayeza anje nge-Interferon kunye ne-Ribavirin, kangangeenyanga ezi-6 ukuya kunyaka-1, kunye ne-interferon ibe yinaliti ekufuneka ilawulwe kube kanye ngeveki, kwaye i-ribavirin ibandakanya ukusela iipilisi yonke imihla.

Unyango olutsha lubonakalisile ukuba lonyusa kakhulu amathuba okunyanga i-hepatitis C kwaye inendibaniselwano yamachiza eSofosbuvir, Simeprevir kunye neDaklinza ekufuneka isetyenziselwe iiveki ezili-12 okanye ezingama-24 ubuncinci, ineziphumo ebezingalindelekanga ezimbalwa kunangaphambili. Olu dibana lweziyobisi kufuneka luthathwe kabini kuphela ngemini kodwa luyaphikiswa xa ukhulelwe.

Nangona kunjalo, olu dibaniso lutsha linexabiso eliphezulu lemali kwaye okwangoku alunikezelwa yi-SUS. Indibaniselwano yesofosbuvir + simeprevir kwiiveki ezili-12 ixabisa malunga namawaka angama-25 reais kunye nokudityaniswa kwesofosbuvir + daclatasvir kangangeeveki ezili-12, malunga namawaka angama-24 reais. Ukongeza kolu dibaniso, ugqirha unokukhetha irejimeni yonyango ebandakanya i-Interferon, i-Ribavirin kunye ne-daclatasvir kangangeeveki ezingama-24, ngexabiso elimalunga ne-16 lamawaka reais.

Unyango kolu nyango luyahluka phakathi kwe-80 kunye ne-100% kuxhomekeke ekubeni ngaba kukho ukuqina kwesibindi nokuba umntu ukhe walufumana na unyango ngaphambili. Kukho ithuba elikhulu lokunyanga xa umntu engekabinayo i-cirrhosis, esandula ukusulelwa okanye efumene unyango lwe-hepatitis ngaphambili okanye usaqhubeka nokunyangwa.

Ndazi njani ukuba ndinyangekile kwi-hepatitis C

Kwiinyanga ezi-6 emva kokuphela konyango oluchazwe ngugqirha, isiguli kufuneka siphinde kuvavanyo lwegazi ALT, AST, alkaline phosphatase, gamma GT kunye neebilirubins, ukubona ukuba intsholongwane iyasuswa na esibindini okanye hayi.

Ukuba intsholongwane ayikasuswa, ugqirha usenokuthi, kwezinye iimeko, amisele umjikelo omtsha wonyango.

Kubalulekile ukulandela unyango oluchazwe ngugqirha ukuzama ukunyanga i-hepatitis C kuba i-hepatitis C ayizinyangi yodwa kwaye ngenxa yokuba i-hepatitis C engapheliyo ineengxaki ezinokubandakanya i-cirrhosis yesibindi kunye nomhlaza wesibindi, apho unyango lunokubandakanya ukufakelwa isibindi.

Jonga iyeza lasekhaya elinokunceda ukunyanga i-hepatitis.

Iziphumo ebezingalindelekanga zamayeza

Amachiza asetyenziswa kakhulu kunyango lwe-hepatitis C, njenge-Interferon, i-Ribavirin, i-Sofosbuvir okanye i-Daklinza ibangela iziphumo ebezingalindelekanga ezifana nentloko, isicaphucaphu, ukugabha, iintlungu emzimbeni wonke, umkhuhlane kunye nokugodola kwaye, ke ngoko, izigulana ezininzi ziyalushiya unyango, ziyanda umngcipheko wokuba nesifo somhlaza nesibindi.

Nantsi indlela isondlo esinokunceda ngayo ukubuyela kwesibindi sakho: